IPASA Innovative Medicines Summit

IPASA Inaugural Innovative Medicines Summit took place 1 September 2016 at the Hyatt Hotel, Rosebank. The Summit was graced by 200 attendees representing a diverse group of industry players, including Policymakers (Government and Funders), Science Councils, Academia, Patient Advocacy Groups, Press, Civil Society Advocacy, Hospitals, Pharmacy Groups, Independent Pharmacy, Doctor Groups, Independent Practitioner and Pharma Industry.

 

The speakers included Honourable Minister Naledi Pandor, Dr. Timmy Kedijang, Prof. Kelly Chibale, Mr. Michael Kleinrock, Dr. Patrice Matchaba, Mr. Richard Bergström, Mr. Greg Perry, Dr. Jonathan Broomberg, Dr. Mark Britnell and Dr. Konji Sebati. The resounding and reoccurring themes of cooperation, collaboration and partnership were echoed through the day.

Patient Testimonials by Raynolda Makhutle (Cancer.vive) and Kelly du Plessis (Rare Disease) left the audience with little doubt of the value of innovation touching their lives, and opportunities beyond their stories.

 

Special recognition to be given to the MC of the day Mr. McLean Sibanda, who elegantly took the attendees through the stimulating programme and panel discussions.

 

A word of thanks to the Task Team that worked tirelessly behind the scenes to ensure this event was a success.

The resounding and reoccurring themes of cooperation, collaboration and partnership were echoed through the day.

Key Speakers

Honourable Minister Naledi Pandor
South African Minister of Science and Technology

 

Dr. Timmy Kedijang
IPASA President

 

Prof. Kelly Chibale
UCT Principal Investigator, Department of Chemistry and IDM

Mr. Michael Kleinrock
IMS Institute, Research Director

 

Dr. Patrice Matchaba
Novartis Global Head Development, US

 

Mr. Richard Bergström
European FPIA Director General

Mr. Greg Perry
Medicines Patent Poll Executive Director

 

Dr. Jonathan Broomberg
Discovery Health CEO

 

Dr. Mark Britnell
KPMG Chairman & Partner of the Global Health Practice

Presentations

Investment in Health Innovation Capacity: The Pre-requisite for South African-led Innovative Pharmaceuticals& Economic Activity Kelly Chibale is a full Professor of Organic Chemistry at the University of Cape Town (UCT) in South Africa. He is also a Full Member of the UCT Institute of Infectious......

Opening Remarks Dr Timmy Kedijang is the current President of IPASA since 2014.  Dr Kedijang is a Medical Doctor by qualification, having graduated with a Bachelors of Medicine and Surgery (MBchB) from University of KwaZulu Natal.  Additionally he holds a Master’s of Science in Clinical......

The Global Trend Towards Personalized Medicine Michael serves as Research Director for the IMS Institute. He writes and speaks regularly on key health care topics related to the current and future place of biopharmaceuticals in healthcare. He brings a deep understanding of complex data sources......

Medicines Discovery & Development – a moral & economic development imperative in Africa: if not now, then when? Patrice Matchaba is the Global Head of Development, Cardio Metabolic Franchise at Novartis Pharmaceuticals. Appointed in May 2014 to this role, Patrice leads the global clinical development......

Medicine Patent Pool – a model for increasing access and innovation of medicines in developing countries Greg Perry joined the Medicines Patent Pool (MPP) as Executive Director in January 2013, bringing more than 20 years of experience in pharmaceuticals, intellectual property and healthcare policy to......

Innovative Reimbursement Dr Jonathan Broomberg is Chief Executive Officer of Discovery Health, South Africa’s largest health insurer, which manages 19 health funds, comprising over 3.3 million members. Jonathan studied medicine at the University of the Witwatersrand, South Africa, and then read PPE at Balliol College......

The Value of Innovation in Healthcare – Healthcare Successes Richard Bergstrom is a pharmacist by training. He received his MScPharm degree from the University of Uppsala, Sweden in 1988. Until 1992 he worked at the Medical Products Agency as Assistant Head of Registration. He moved......

Official MC for the IPASA Innovative Medicines Summit 2016 McLean Sibanda is an engineer and patent attorney. He has recently been appointed for a second term as the Chief Executive Officer of The Innovation Hub, a leading African Science Park. He has extensive experience in......

Recently appointed the CEO of IPASA, the Innovative Pharmaceutical Association of South Africa; Konji has over 25 years’ experience in the Public and Private sector. She is a Medical Practitioner by training, with a Bachelor of Science degree from the University of the North (now......

Articles

Medical research and development relating to a wide range of chronic diseases endemic to Africa will be a central theme at the IPASA Innovative Medicines Summit being held on September 1. The Innovative Pharmaceutical Association South Africa (IPASA) is a voluntary trade association that represents......

Written on behalf of IPASA by Shelley McGee, B.Sc, B.Pharm, M HealthEcon, Health Policy and Patient Access Manager: Sanofi – South Africa   Scientists in the US believe they’re closing in on a cure for type 1 diabetes through immune targeting, potentially bringing to closure......

Issued by IPASA When you consider that HIV/Aids only really came to the world’s attention 35 years ago, it’s truly amazing that it has gone from a certain death sentence to a chronic manageable disease in such a short time. Similarly, effective treatment for tuberculosis......

Issued by IPASA We’ve become accustomed to taking medicines: you get sick, see your doctor, get a prescription and your friendly pharmacist gives you the drugs you need. But few people consider what it takes for those medications to arrive on the shelf – on......

Issued by IPASA The world would look very different without many of the drugs we have come to take for granted – antibiotics, anti-malarials and antiretrovirals come to mind. But there are still many diseases for which we have not yet found cures. Just think......

– by Dr Konji Sebati, CEO of the Innovative Pharmaceutical Association South Africa (IPASA)   “The impact of vaccination on the health of the world’s people is hard to exaggerate. With the exception of safe water, no other modality, not even antibiotics, has had such......

Issued by IPASA It’s only been 10 years since the vaccine against human papillomavirus (HPV) was launched, but already several international studies have shown that it is effective and is working – better than expected, in fact. For those girls and women who have been......

Gallery